146 related articles for article (PubMed ID: 8159284)
21. The effect of atrial natriuretic factor on arginine-8-vasopressin and oxytocin levels in various brain regions and plasma.
Laczi F; Vecsernyés M; Kovács GL; Penke B; Jójárt I; Janáky T; Telegdy G; László FA
Exp Clin Endocrinol; 1988 Mar; 92(3):328-34. PubMed ID: 2978124
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
Muret L; Priou A; Oliver C; Grino M
Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256
[TBL] [Abstract][Full Text] [Related]
23. Effect of ether stress on growth hormone during development in the neonatal rat.
Eck JB; Kuhn CM
Neuroendocrinology; 1992 Nov; 56(5):605-10. PubMed ID: 1488092
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of dynamics of corticotropin-releasing factor (CRF) activity in the rat hypothalamus under stress].
Fujieda K
Hokkaido Igaku Zasshi; 1976 May; 51(3):199-216. PubMed ID: 184025
[TBL] [Abstract][Full Text] [Related]
25. Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced secretion of ACTH and corticosterone.
Alexander LD; Sander LD
Neuropeptides; 1995 Mar; 28(3):167-73. PubMed ID: 7791960
[TBL] [Abstract][Full Text] [Related]
26. A study on the release mechanism of vasopressin and oxytocin.
Hashimoto H; Noto T; Nakajima T
Neuropeptides; 1988; 12(4):199-206. PubMed ID: 3237319
[TBL] [Abstract][Full Text] [Related]
27. Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress.
Ono N; Bedran de Castro JC; McCann SM
Proc Natl Acad Sci U S A; 1985 May; 82(10):3528-31. PubMed ID: 2987931
[TBL] [Abstract][Full Text] [Related]
28. [Effects of adrenal medullectomy and passive immunization with an anti-CRF antiserum on the corticotropin secretion in response to stress in Long-Evans rats].
Rey M; Guillaume V; Conte-Devolx B; Mercier GM; Boudouresque F; Grino M; Oliver C
C R Acad Sci III; 1984; 299(12):515-20. PubMed ID: 6093952
[TBL] [Abstract][Full Text] [Related]
29. Effect of acute ether or restraint stress on plasma corticotropin-releasing hormone, vasopressin and oxytocin levels in the rat.
Hashimoto K; Murakami K; Takao T; Makino S; Sugawara M; Ota Z
Acta Med Okayama; 1989 Jun; 43(3):161-7. PubMed ID: 2548372
[TBL] [Abstract][Full Text] [Related]
30. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
[TBL] [Abstract][Full Text] [Related]
31. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
Plotsky PM; Sawchenko PE
Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
[TBL] [Abstract][Full Text] [Related]
32. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
[TBL] [Abstract][Full Text] [Related]
33. Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats.
Keck ME; Hatzinger M; Wotjak CT; Landgraf R; Holsboer F; Neumann ID
Eur J Neurosci; 2000 Apr; 12(4):1487-94. PubMed ID: 10762376
[TBL] [Abstract][Full Text] [Related]
34. Interaction of arginine vasopressin and corticotropin releasing factor demonstrated with an improved bioassay.
Graf MV; Kastin AJ; Fischman AJ
Proc Soc Exp Biol Med; 1985 Jul; 179(3):303-8. PubMed ID: 3873659
[TBL] [Abstract][Full Text] [Related]
35. Stimulus-induced depletion of pro-enkephalins, oxytocin and vasopressin and pro-enkephalin interaction with posterior pituitary hormone release in vitro.
Leng G; Bicknell RJ; Brown D; Bowden C; Chapman C; Russell JA
Neuroendocrinology; 1994 Dec; 60(6):559-66. PubMed ID: 7700499
[TBL] [Abstract][Full Text] [Related]
36. Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia.
Plotsky PM; Bruhn TO; Vale W
Endocrinology; 1985 Jul; 117(1):323-9. PubMed ID: 2988921
[TBL] [Abstract][Full Text] [Related]
37. Effects of corticosterone on the secretion of corticotrophin-releasing factor, arginine vasopressin and oxytocin into hypophysial portal blood in long-term hypophysectomized rats.
Sheward WJ; Fink G
J Endocrinol; 1991 Apr; 129(1):91-8. PubMed ID: 2030334
[TBL] [Abstract][Full Text] [Related]
38. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
Ogilvie KM; Lee S; Rivier C
Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
[TBL] [Abstract][Full Text] [Related]
39. Plasma levels of luteinizing hormone during hyperprolactinemia: response to central administration of antagonists of corticotropin-releasing factor.
de Greef WJ; Ooms MP; Vreeburg JT; Weber RF
Neuroendocrinology; 1995 Jan; 61(1):19-26. PubMed ID: 7731494
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):603-10. PubMed ID: 9402040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
